Low-dose aspirin does not lower the risk of colorectal cancer in patients with type 2 diabetes taking metformin

Nov-22

AUTHORS : Esther W. Chan, Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong – Email:ewchan@hku.hk

JOURNAL : Journal of Internal Medicine

REFERENCE: 293(3):371-383

DOI : 10.1111/joim.13590

Low-dose aspirin does not lower the risk of colorectal cancer in patients with type 2 diabetes taking metformin

More publications

Evaluating the potential impact of lifestyle‑based behavior change interventions delivered at the time of colorectal cancer screening

Association of Adherence to Endocrine Therapy Among Patients With Breast Cancer and Potential Drug-Drug Interactions

Impact of the third national ‘Be Clear on Cancer’ Breast Cancer in Women over 70 Campaign on general practitioner attendance and referral, diagnosis rates and prevalence awareness